Abstract: Compounds according to Formula (I) or a salt thereof are selective ligands for GABAA receptors useful for treatment of disorders of the central nervous system:
Type:
Grant
Filed:
January 4, 2001
Date of Patent:
March 5, 2002
Assignee:
Merck Sharp & Dohme Limited
Inventors:
Ian James Collins, Stephen Robert Fletcher, Timothy Harrison, Paul David Leeson, Christopher Richard Moyes, Alan John Nadin, Michael Rowley, Timothy Jason Sparey, Martin Richard Teall
Abstract: Phenylpiperazine derivatives having high affinity for the &agr;1-adrenoreceptor and pharmaceutical compositions containing them. Also disclosed is a method of using the such derivatives to treat benign prostatic hyperplasia.
Type:
Grant
Filed:
September 28, 1998
Date of Patent:
October 9, 2001
Assignee:
Societe de Conseils de Recherches et d'Applications
Scientifiques (S.C.R.A.S.)
Inventors:
Dennis Bigg, Pierre Etienne Chabrier de Lassauniere, Serge Auvin, Michel Auguet
Abstract: The present invention is concerned with a novel process for the preparation of N-benzyl-3-(4-fluorophenyl)-1,4-oxazin-2-one of the formula:
This compound is useful as an intermediate in the synthesis of compounds which possess pharmacological activity, in particular, as substance P (neurokinin-1) receptor antagonists.
Abstract: Perylene hydrazide imides of the general formula I a process for the preparation thereof, the use thereof as detection reagents for carbonyl compounds, protonic acids, acylating agents and metal salts, and also perylene hydrazones II and bi- and tri-fluorophoric perylene bisimides III, the preparation thereof and methods of using them.
Abstract: The present invention relates to certain spiro-azacyclic derivatives which are tachykinin antagonists and are useful, for example, in the treatment or prevention of pain, inflammation, migraine, emesis and postherpetic neuralgia.
Type:
Grant
Filed:
March 23, 1999
Date of Patent:
April 4, 2000
Assignee:
Merck Sharp & Dohme Ltd.
Inventors:
Karen Elizabeth Haworth, Eileen Mary Seward, Christopher John Swain